Home
Storia in 1 fonti
How the UK fell out with big pharma
The U.K. is in the midst of a falling out with big pharma over drug pricing. Merck has walked away from a £1 billion facility in London and pulled its research activities altogether. Now Eli Lilly, Sanofi and AstraZeneca are all rethinking their investments in the country. CNBC's Ritika Gupta discusses with Jimmy Muchechetere, global healthcare & industrials equity research analyst at Investec.
Raccontata da
cnbc.com
- ·
How the UK fell out with big pharma
The U.K. is in the midst of a falling out with big pharma over drug pricing. Merck has walked away from a £1 billion facility in London and pulled its research activities…
- ·
Pharma firms pile pressure on the UK as Trump's drug pricing order looms
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.
- ·
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U.S. policymakers.